Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments
0301 basic medicine
0303 health sciences
Superoxide Dismutase
Bone Marrow Cells
Cell Differentiation
Mesenchymal Stem Cells
Hep G2 Cells
Antioxidants
Lipocalins
Rats
Up-Regulation
Rats, Sprague-Dawley
03 medical and health sciences
Cellular Microenvironment
Lipocalin-2
Proto-Oncogene Proteins
Cell Adhesion
Animals
Humans
Intercellular Signaling Peptides and Proteins
Heme Oxygenase-1
Acute-Phase Proteins
Cell Proliferation
DOI:
10.1007/s12192-013-0430-2
Publication Date:
2013-05-01T11:06:13Z
AUTHORS (4)
ABSTRACT
Despite many advantages of mesenchymal stem cells (MSCs) that make them suitable for cell therapy purposes, their therapeutic application has been limited due to susceptibility several stresses (e.g., nutrient-poor environment, oxidative stress, and hypoxic masses cytotoxic factors) which they are exposed during preparation following transplantation. Hence, reinforcing MSCs against these is a challenge both basic clinician scientists. Recently, much attention directed toward equipping with cytoprotective factors strengthen unfavorable microenvironments. Here, we engineered lipocalin 2 (Lcn2), factor naturally induced exposure imposed by the microenvironment. Lcn2 overexpression not only did interfere multidifferentiation capacity but also granted protective properties them. potentiated withstand oxidative, hypoxia, serum deprivation (SD) conditions via antagonizing cytotoxicity apoptosis. Adhesion rate coated culture plates was enhanced overexpression. In addition, antioxidants upregulated some growth in MSCs. Our findings suggested new strategy prevention graft death MSC-based therapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (42)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....